PTC Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Date: November 19, 2014
Pages: 36
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: P6D97493F76EN
Leaflet:

Download PDF Leaflet

PTC Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary

PTC Therapeutics, Inc. (PTC) is a biopharmaceutical company. The company discovers, develops, and commercializes the orally administered small-molecule drugs to alter post-transcriptional processes. Its post-transcriptional control processes regulate the rate and timing of protein production and proper cellular function. The company’s current pipeline of clinical and preclinical product candidates addresses multiple indications, including genetic disorders, oncology, and infectious diseases. PTC offers Ataluren, an investigational drug to helps the formation of a functioning protein in patients with genetic disorders due to a nonsense mutation. It is collaborated with AstraZeneca, Celgene Corporation, Gilead, Merck & Co., Inc., Pfizer Inc and among others. PTC is headquartered in South Plainfield, New Jersey, the US.

PTC Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.
PTC Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
PTC Therapeutics, Inc., Pharmaceuticals & Healthcare Deals By Type, 2008 to YTD 2014
PTC Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014
PTC Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014
PTC Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2008 to YTD 2014
PTC Therapeutics, Inc., Pharmaceuticals & Healthcare, Deal Details
Venture Financing
PTC Therapeutics Raises US$60 Million In Venture Financing
PTC Therapeutics Raises US$2 Million In Venture Financing
Ptc Therapeutics Raises US$30 Million In Venture Financing
PTC Therapeutics Secures US$50 Million In Venture Financing
Partnerships
Dualsystems Biotech Enters Into Agreement With PTC Therapeutics For Drug Profiling
PTC Therapeutics Expands Its Collaboration With Parent Project Muscular Dystrophy
Celgene Exercises Option On An Drug Discovery Collaboration With PTC Therapeutics
PTC Therapeutics Expands Co-Development Agreement With Spinal Muscular Atrophy
Genzyme Enters Into Agreement With PTC Therapeutics
Licensing Agreements
Roche Enters Into Licensing Agreement With PTC Therapeutics And SMA Foundation
AstraZeneca Enters Into Collaboration And Licensing Agreement With PTC Therapeutics
PTC Therapeutics Enters Into Licensing Agreement With F. Hoffmann-La Roche
Equity Offering
PTC Therapeutics Raises USD125 Million in Public Offering of Shares
PTC Therapeutics Completes Public Offering Of Shares For US$126.5 Million
PTC Therapeutics Completes IPO For US$144.4 Million
PTC Therapeutics, Inc. - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

PTC Therapeutics, Inc., Pharmaceuticals & Healthcare, Key Facts, 2013
PTC Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
PTC Therapeutics, Inc., Pharmaceuticals & Healthcare Deals By Type, 2008 to YTD 2014
PTC Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014
PTC Therapeutics, Inc., Deals By Therapy Area, 2008 to YTD 2014
PTC Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2008 to YTD 2014
PTC Therapeutics Raises US$60 Million In Venture Financing
PTC Therapeutics Raises US$2 Million In Venture Financing
Ptc Therapeutics Raises US$30 Million In Venture Financing
PTC Therapeutics Secures US$50 Million In Venture Financing
Dualsystems Biotech Enters Into Agreement With PTC Therapeutics For Drug Profiling
PTC Therapeutics Expands Its Collaboration With Parent Project Muscular Dystrophy
Celgene Exercises Option On An Drug Discovery Collaboration With PTC Therapeutics
PTC Therapeutics Expands Co-Development Agreement With Spinal Muscular Atrophy
Genzyme Enters Into Agreement With PTC Therapeutics
Roche Enters Into Licensing Agreement With PTC Therapeutics And SMA Foundation
AstraZeneca Enters Into Collaboration And Licensing Agreement With PTC Therapeutics
PTC Therapeutics Enters Into Licensing Agreement With F. Hoffmann-La Roche
PTC Therapeutics Raises USD125 Million in Public Offering of Shares
PTC Therapeutics Completes Public Offering Of Shares For US$126.5 Million
PTC Therapeutics Completes IPO For US$144.4 Million
PTC Therapeutics, Inc., Key Competitors
PTC Therapeutics, Inc., Key Employees

LIST OF FIGURES

PTC Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014
PTC Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
PTC Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014
PTC Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014
PTC Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
PTC Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014
PTC Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014
PTC Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014
Skip to top


Ask Your Question

PTC Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: